MOXIFLOXACIN HYDROC

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of 1.000 pound of MOXIFLOXACIN HYDROC with National Stock Number 6505015163194, at a fixed price of $862.50. The order, issued on July 15, 2026, is a sole-source acquisition with zero quantity variance, meaning no substitutions or adjustments to the quantity are permitted. Delivery is required FOB destination to Dyess Air Force Base, Texas, with the contractor responsible for all transportation costs and required to use traceable shipping methods—parcel post is prohibited. Inspection and acceptance occur at the destination by Government personnel, and the item must conform strictly to contract specifications. Invoices must be submitted in accordance with DFARS 252.232-7003, implying use of the Wide Area Workflow system. Payment will be processed through the Defense Finance and Accounting Service in Columbus, Ohio, using the BX code 97X4930 5CBX 001 2620 S33189 and the PR number 7017513311. The procurement is governed by standard federal acquisition regulations, with no explicit socioeconomic set-asides, specialized packaging standards, or MIL-STDs cited, though compliance with DoD logistics identifiers and procedures is implied. Contract administration is managed by Lisa Quinn as the Contracting Officer and Shairy M. Cartagena as the local administrator, with no COR or COTR named. The contractor’s manufacturer, identified by CAGE 1XUY5, is also referenced, and while CAGE code is provided, no Unique Entity ID, size status, or socioeconomic certifications are explicitly declared. The award is consistent with a Lowest Price Technically Acceptable approach typical for DLA pharmaceutical acquisitions, where technical acceptability is presumed due to FDA-standardized pharmaceuticals and price is the decisive factor.